4//SEC Filing
Zalevsky Jonathan 4
Accession 0000950170-25-113130
CIK 0000906709other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 9:02 PM ET
Size
5.3 KB
Accession
0000950170-25-113130
Insider Transaction Report
Form 4
Zalevsky Jonathan
Chief R&D Officer
Transactions
- Sale
Common Stock
2025-09-02$30.10/sh−485$14,599→ 19,183 total
Footnotes (2)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]This transaction was executed in multiple trades at prices ranging from $30.00 to $30.28 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
Documents
Issuer
NEKTAR THERAPEUTICS
CIK 0000906709
Entity typeother
Related Parties
1- filerCIK 0001789857
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 9:02 PM ET
- Size
- 5.3 KB